Cargando…

Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas.

Nine primary pulmonary carcinomas, one metastatic carcinoma, and two malignant pleural mesotheliomas have been analysed for the expression at the mRNA level of metalloproteinases (MPs) and tissue inhibitors of MPs (TIMPs). In situ hybridisation showed TIMP-1 and TIMP-2 transcripts predominantly over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urbanski, S. J., Edwards, D. R., Maitland, A., Leco, K. J., Watson, A., Kossakowska, A. E.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1992
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978055/ https://www.ncbi.nlm.nih.gov/pubmed/1457364

Ejemplares similares

Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
por: Kossakowska, A. E., et al.
Publicado: (1996)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma.
por: Mimori, K., et al.
Publicado: (1997)

Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma
por: Qiao, Zhen-kui, et al.
Publicado: (2013)

Expression of Tissue Inhibitors of Metalloproteinases (TIMPs) in Hepatocellular Carcinoma
por: Joo, Young-Eun, et al.
Publicado: (2000)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2020)

Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
por: Joo, Y. E., et al.
Publicado: (1999)

Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas
por: Forsyth, P A, et al.
Publicado: (1999)

Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption
por: Young, David A, et al.
Publicado: (2005)

Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma
por: Wallard, M J, et al.
Publicado: (2006)

Production of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Breast Carcinomas
por: Iwata, Hiroji, et al.
Publicado: (1996)

Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease
por: Zhang, Yongxiang, et al.
Publicado: (2020)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma
por: Grzelczyk, Weronika Lucas, et al.
Publicado: (2019)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
por: Todd, Jamie L., et al.
Publicado: (2020)

The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro
por: Alain, T, et al.
Publicado: (2006)

Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage
por: Davidson, Rose K, et al.
Publicado: (2006)

Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9
por: Ordonez, Alvaro A., et al.
Publicado: (2016)

Reduced expression of tissue inhibitor of metalloproteinase in nodal metastasis of stomach cancer.
por: Ko, B. K., et al.
Publicado: (1998)

Expression of Matrix Metalloproteinases and Their Inhibitors in Squamous Cell Carcinoma of the Tonsil and Their Clinical Significance
por: Lee, Sei Young, et al.
Publicado: (2011)

Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model.
por: Watson, S. A., et al.
Publicado: (1996)

The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma
por: LU, HONGSHENG, et al.
Publicado: (2013)

Expression of Matrix Metalloproteinase-2/9 and Tissue Inhibitor of Metalloproteinase-1/2 as Predictive Factors in Oropharyngeal Squamous Cell Carcinoma
por: Burduk, Pawel-Krzysztof, et al.
Publicado: (2019)

Associations between matrix metalloproteinase, tissue inhibitor of metalloproteinase and collagen expression levels in the adjacent rectal tissue of colorectal carcinoma patients
por: Dibdiakova, Katarina, et al.
Publicado: (2022)

Serum metalloproteinases and their inhibitors: markers for malignant potential.
por: Baker, T., et al.
Publicado: (1994)

Imbalance of Pulmonary Microvascular Endothelial Cell-Expression of Metalloproteinases and Their Endogenous Inhibitors Promotes Septic Barrier Dysfunction †
por: Jayawardena, Devika P., et al.
Publicado: (2023)

Expression of Matrix Metalloproteinase-2 and -13 and Tissue Inhibitor of Metalloproteinase-4 in Varicose Veins
por: Chang, Jee Won, et al.
Publicado: (2011)

Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases
por: Yamada, Hiroshi, et al.
Publicado: (2016)

Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Endometriosis Menstrual Blood
por: Madjid, Tita Husnitawati, et al.
Publicado: (2020)

Gene Expression of Matrix Metalloproteinases and their Inhibitors (TIMPs) in Meningiomas of Dogs
por: Mandara, M.T., et al.
Publicado: (2017)

Blocking human fear memory with the matrix metalloproteinase inhibitor doxycycline
por: Bach, D R, et al.
Publicado: (2017)

Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma
por: WAJNER, SIMONE MAGAGNIN, et al.
Publicado: (2014)

Matrix Metalloproteinase Expression Patterns in Luminal A Type Breast Carcinomas
por: Decock, J., et al.
Publicado: (2007)

Study of matrix metalloproteinases and their inhibitors in breast cancer
por: Vizoso, F J, et al.
Publicado: (2007)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Echinoderms: Structure and Possible Functions
por: Dolmatov, Igor Yu., et al.
Publicado: (2021)

The ADAM metalloproteinases
por: Edwards, Dylan R., et al.
Publicado: (2008)

Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013)

Differential Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Thioacetamide-Induced Chronic Liver Injury
por: Park, Soo Young, et al.
Publicado: (2010)

Study of matrix metalloproteinases and their inhibitors in prostate cancer
por: Escaff, S, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tt1itepsjui5pqs40s2o0u6ume